...
首页> 外文期刊>World neurosurgery >A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review
【24h】

A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review

机译:动脉瘤性蛛网膜下腔出血后血管痉挛超急性发作的案例,用静脉内和脑内一氧化氮处理的耐火血管痉挛:迷你评论

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: A case of hyperacute vasospasm, indicating a poor prognosis after aneurysmal subarachnoid hemorrhage (SAH), is reported, and a review is presented of the literature addressing use of nitric oxide (NO) donors in cases of refractory vasospasm and recurrent delayed cortical ischemias (DCI). CASE DESCRIPTION: A 65-year-old woman was admitted within 1 hour after aneurysmal SAH (Hunt and Hess grade III, Fisher modified by Frontera grade IV). A hyperacute vasospasm had been confirmed arteriographically, the right middle cerebral artery (MCA) aneurysm was immediately coiled and a standard antivasospastic therapy was started. Within 48 hours, the patient developed cerebral vasospasm with DCI. Because the standard therapy failed to control clinical symptoms and to address severe vasospasm, an individualized rescue treatment with NO donors was initiated. A continuous intravenous molsidomine infusion was started and clinical stabilization was achieved for a week (Hunt and Hess grade I; World Federation of Neurological Surgeons grade I; Glasgow Coma Scale score, 15) after which vasospasm and DCI recurred. During a subsequent DCI, we escalated NO donor therapy by adding intraventricular boluses of sodium nitroprusside (SNP). Over the course of the following 22 days, 7 transient DCIs (Glasgow Coma Scale score, 8) were treated with boluses of SNP during continued molsidomine therapy and each time vasospasm and DCI were completely reversed. Despite initial poor prognosis, the clinical outcome was excellent; at 3, 6, and 12 months follow-up the patient's modified National Institutes of Health-Stroke Scale and modified Rankin Scale scores were 0, with no cognitive deficits.
机译:背景:报告了一种超急性血管痉挛的情况,表明动脉瘤性蛛网膜下腔出血(SAH)预后差,并提出了在难治性血管痉挛和复发延迟皮质缺血的情况下使用一氧化氮(NO)供体的文献(DCI)。案例描述:一名65岁的女性在1小时后1小时内接纳了通风瘤SAH(亨特和Hess级III,Fishera级IV修改的Fisher)。已经证实了大缩短血管痉挛的动脉造影,右中脑动脉(MCA)动脉瘤立即线圈,并开始了标准的防蒸求疗法。在48小时内,患者患有DCI的脑血管痉挛。由于标准疗法未能控制临床症状并解决严重血管痉挛,因此未启动无捐赠者的个性化救援治疗。开始持续静脉内莫里西亚甲酰胺输注,并达到临床稳定一周(狩猎和HESS等级I;世界神经外科医生等级I; Glasgow Coma Scade,15)之后,血管痉挛和DCI重复。在随后的DCI期间,通过添加硝普钠(SNP)的腔内推注,我们不会升级供体疗法。在以下22天内,在持续的摩尔咪唑疗法期间用SNP的推注处理7瞬态DCIS(Glasgow Coma Scale评分,8),并且每次血管痉挛和DCI都完全逆转。尽管预后较差差,但临床结果是优秀的;在3,6和12个月后,患者改进的国家卫生冲程规模和改进的Rankin规模得分为0,没有认知赤字。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号